World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   6468 records for 1429 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingCTRI/2014/12/005334
Phase III multicenter, double-blind, randomized, parallel-group study to evaluate safety and efficacy of Hercules plus Taxane Herceptin® plus Taxane as First Line therapy in Her2-Positive Metastatic Breast cancer.
30-12-2014
Not recruitingNCT02322775
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
19/12/2014
RecruitingNCT02325804
Effect of Specific Diet and Physical Activity on Weight and/or Fat Loss
05/12/2014
AuthorisedEUCTR2014-003135-19-PL
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE STUDY OF SD-809 (DEUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA
18/11/2014
Not recruitingNCT02291289
A Multi-Center Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer
11/11/2014
RecruitingNCT02290028
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
10/11/2014
RecruitingNCT02292446
Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.
05/11/2014
RecruitingNCT02299375
Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)
03/11/2014
AuthorisedEUCTR2014-002275-28-FI
Comparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02296138Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.19/11/2014
AuthorisedEUCTR2014-002275-28-PTComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.10/11/2014
AuthorisedEUCTR2014-002275-28-NLComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.18/11/2014
AuthorisedEUCTR2014-002275-28-HUComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.19/11/2014
AuthorisedEUCTR2014-002275-28-ATComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.27/11/2014
AuthorisedEUCTR2014-002275-28-DKComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.13/11/2014
28/10/2014
AuthorisedEUCTR2013-005164-26-AT
A 52 week clinical trial with the test compound DS-5565, in patients who suffer from pain related to fibromyalgia
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-005164-26-HUA 52 week clinical trial with the test compound DS-5565, in patients who suffer from pain related to fibromyalgia26/11/2014
28/10/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history